sellWeak
Andrew Spaventa sold $2,167 of OMIC
Chief Executive Officer at Singular Genomics Systems, Inc.. 175 shares at an average of $12.38, traded Sep 15, 2024, filed Sep 17, 2024.
Warning score
15Value
$2,167
175 shares
Holdings after
637
-22% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- 0Trade size$2k at market
- +5Share of holdings soldSold 22% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-107502, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 15, 2024 | MOption exercise Common Stock | +487 | - | - | 812 | Sep 17, 2024 |
| Sep 15, 2024 | SOpen-market sale Common Stock | -175 | $12.38 | $2,167 | 637 | Sep 17, 2024 |
| Sep 15, 2024 | GGift Common Stock | -312 | $0.00 | $0 | 325 | Sep 17, 2024 |
| Sep 15, 2024 | GGift Common Stockindirect: By The Andrew K. Spaventa Living Trust dated April 9, 2014 | +312 | $0.00 | $0 | 140,275 | Sep 17, 2024 |
| Sep 15, 2024 | MOption exercise Restricted Stock Unitsderivative | -487 | $0.00 | $0 | 4,860 | Sep 17, 2024 |
Related signals
Other insiders at Singular Genomics Systems, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | OMICsell Singular Genomics Systems, Inc. | Andrew Spaventa Chief Executive Officer | $3,629 180 shares | -22% | |
| 20Weak | OMICsell Singular Genomics Systems, Inc. | Andrew Spaventa Chief Executive Officer | $16k 695 shares | -31% | |
| 48Moderate | OMICbuy Singular Genomics Systems, Inc. | Kevin Tang owner | $1.8M 122,416 shares | +49% | |
| 32Weak | Singular Genomics Systems, Inc. | Eli N. Glezer Chief Scientific Officer | $86k 200,000 shares | +5% | |
| 40Moderate | Singular Genomics Systems, Inc. | Andrew Spaventa Chief Executive Officer | $50k 118,468 shares | +3% | |
| 25Weak | OMICbuy Singular Genomics Systems, Inc. | Eli N. Glezer Chief Scientific Officer | $100k 50,000 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.